Biodesix, Inc has expanded its long-standing collaboration with Bio-Rad Laboratories to co-develop and clinically validate ...
The Colorado firm is expanding its partnerships, outreach efforts, technology applications, and sales force for its oncology screening and monitoring test business.
A ustralia's sunscreen scandal is deepening with twenty-one products under scrutiny, all linked to a Perth lab, accused of ...
A Bay Area biotech company is behind a potentially groundbreaking blood test that promises to be a game-changer in cancer ...
A new blood test for cancer DNA — the genetic code that differentiates cancer from healthy tissue — allows doctors to ...
Biodesix has expanded its collaboration with Bio-Rad for the development and clinical validation of in vitro diagnostic (IVD) ...
Biodesix will perform the clinical validation of ddPLEX ESR1 Mutation Detection Assay for advanced breast cancer testing.
Neoadjuvant Enhertu then THP improved pathological complete response rate in patients with high-risk, HER2-positive early ...
A pioneering blood test designed to screen for more than 50 types of cancer, currently being evaluated by the NHS, has correctly identified the disease in nearly two-thirds of cases it flagged. The ...
Hosted on MSN
Could simple blood tests identify cancer earlier?
Around four years ago, now 77-year-old John Gormly went for what was supposed to be a routine blood test. But the results were life-changing. The test suggested Gormly had colon cancer, which a ...
LONDON — A blood test that screens for more than 50 cancers is correct in 62% of cases where it thinks people may have the disease, a study has found. The Galleri test, which can be given annually and ...
Editor’s note: This story was updated to clarify recommendations for colorectal cancer screening. As a gastroenterologist, the most meaningful part of my job is preventing colorectal cancer by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback